Immutep Health Care
Cancer Pharmaceuticals

$0.315 0.010 (3.28%)

High $0.32	Low $0.30	Trades 243	Turnover $627,825	Volume 2,012,212
30 June 2023 at 4:10pm

Market Cap (14-Sep) $82,528,400 (530th)	Close (30-Jun) $0.315 0 (0%)	Volume (30-Jun) 2,012,212	Shortsold (8-Sep) 31,138,477 (2.11%) (150th)
52w High $0.470	52w Low $0.028	P/E 7.20	EPS -0.05

Short Interest

ASIC data, 8 Sep 2026

% Shorted

2.11% 0.01

vs 2.12% prior report

Most Shorted Rank

150th

of 694 shorted ASX stocks

Peak Short

3.74%

Jul 2026

Days to Cover

3.4

at 50d avg vol

View full short position history →

	Subject
	IMM IMM Ann: Application for quotation of securities - IMM
	1 (current) 2 3
	IMM IMM Ann: Proposed issue of securities - IMM
	IMM IMM Ann: Notification regarding unquoted securities - IMM
	IMM IMM Ann: Results of Meeting
	IMM IMM Ann: Immutep AGM 2021 - CEO's Presentation
	IMM IMM Ann: Immutep AGM 2021 - Chairman's Address
	IMM IMM Ann: Phase II TACTI-002 trial recruitment successfully completed
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Immutep Global Webcast Slides to Discuss Clinical Results
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Immutep announces publication of SITC 2021 posters
	IMM IMM Ann: Chinese Patent Granted for Efti with PD-1 Pathway Inhibitors
	IMM IMM Article: Why big biotechs will have their eyes on Immutep
	IMM IMM Ann: Immutep announces publication of SITC 2021 abstracts
	IMM IMM Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC
	IMM IMM Ann: JobKeeper Payment Notice
	IMM IMM Ann: Immutep granted Chinese Patent for eftilagimod alpha
	IMM IMM Ann: Immutep receives EMA scientific advice for Phase 3 in MBC
	IMM IMM Ann: Immutep Quarterly Activities Report & Appendix 4C
	IMM IMM Ann: Notice of Annual General Meeting/Proxy Form
	IMM IMM Ann: Appendix 4G
	IMM IMM Ann: Annual Report to shareholders
	IMM IMM Ann: Annual Report filed on Form 20-F with SEC
	IMM IMM Ann: 2021 AGM & Key Dates
	IMM IMM Ann: Ceasing to be a substantial holder from AEF
	IMM IMM Ann: Change of Director's Interest Notice - Mr Chamberlain
	IMM IMM Ann: Change of Director's Interest Notice - Mr Meyers
	IMM IMM Ann: Immutep to present Phase II TACTI-002 data at SITC 2021
	IMM IMM Ann: Notification regarding unquoted securities - IMM
	IMM IMM Ann: Application for quotation of securities - IMM
	IMM IMM Ann: Immutep Receives A$3.4 million R&D French Tax Incentive
	IMM IMM Ann: Immutep to Present at Healthcare Investor Conferences
	IMM IMM Ann: Immutep Corporate Presentation
	IMM IMM Ann: Immutep to present final AIPAC Overall Survival data at SITC
	IMM IMM Ann: Recruitment of patients completed for Part B of TACTI-002
	IMM IMM Ann: Immutep's partner, EOC Pharma, expands efti trial pipeline
	IMM IMM Ann: Appendix 4E & 2021 Full Year Statutory Accounts
	IMM IMM Ann: Chinese patent granted for anti-LAG-3 antibody LAG525
	IMM IMM Ann: INSIGHT-003 investigator-initiated trial - 1st patient dosed
	IMM IMM Ann: Becoming a substantial holder
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Cleansing Notice
	IMM IMM Ann: Completion of Placement - Tranche 2
	IMM IMM Ann: Application for quotation of securities - IMM
	IMM IMM Ann: Change in substantial holding
	IMM IMM Ann: Proposed issue of securities - IMM
	IMM IMM Ann: Results of EGM
	IMM IMM Ann: Chairman's EGM Address
	IMM IMM Ann: 2021 EGM Presentation
	IMM IMM Ann: Application for quotation of securities - IMM

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
14-Sep	$0.05	21,113,896	-0.01 (16.07%)
11-Sep	$0.06	45,816,068	+0.01 (27.27%)
10-Sep	$0.04	12,826,028	0.00 (4.35%)
09-Sep	$0.05	8,083,492	0.00 (2.13%)
08-Sep	$0.05	5,376,462	+0.00 (2.17%)
07-Sep	$0.05	4,456,966	0.00 (4.17%)
04-Sep	$0.05	6,506,328	+0.00 (2.13%)
03-Sep	$0.05	3,338,224	0.00 (4.08%)
02-Sep	$0.05	2,354,360	0.00 (3.92%)
01-Sep	$0.05	4,914,512	+0.00 (6.25%)
31-Aug	$0.05	4,218,452	0.00 (4.00%)
28-Aug	$0.05	2,519,726	0.00 (0.00%)
27-Aug	$0.05	3,104,572	0.00 (3.85%)
26-Aug	$0.05	1,697,268	0.00 (3.70%)
25-Aug	$0.05	4,418,485	+0.00 (1.89%)
5 up, 9 down, and 1 flat days

Immutep Health Care
Cancer Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

IMM Immutep Health Care Cancer Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Immutep Health Care
Cancer Pharmaceuticals